Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic among drugs selected for Medicare price negotiations as Biden exits
The Biden administration announced on Friday the selection of the next 15 prescription drugs that will undergo price negotiations between manufacturers and Medicare, three days before President-elect Donald Trump is set to take office and take over the program.
Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Ozempic, Ibrance among next drugs picked by Medicare for price talks
Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to<a class="excerpt-read-more" href=" More
White House says popular weight-loss drug Ozempic subject to Medicare talks
The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a round of price negotiations with Medicare. The companies do not have to negotiate,
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
15h
on MSN
What Is Agenda47? What To Know About Trump’s Policy Agenda Before His Inauguration
Education: Trump’s proposals for K-12 schools include having parents elect school principals, cutting federal funding to any ...
Investor's Business Daily on MSN
10h
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
1d
on MSN
Treasury Nominee Scott Bessent Calls for a ‘New Economic Golden Age’ Under Trump
Scott Bessent, President-elect Donald Trump's choice to be Secretary of the Treasury, appears before the Senate Finance ...
1d
Employers outline health priorities under Trump
Groups representing employers that offer health insurance are gearing up to defend and try to bolster the largest source of ...
10d
on MSN
Johnson says no cuts to Social Security and Medicare to fund Trump's agenda
House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out ...
1d
on MSN
Gallup: Many Americans skeptical about Trump helping lower cost of healthcare
President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, ...
5d
Medicare and telehealth: more restrictive rules could hit patients in 2025
Instead, people on Medicare won’t get the two years of continued coverage for telehealth appointments and five years’ for ...
5d
on MSN
Social Security Update: Economist Warns Trump Plan May Speed Up Insolvency
Francois Melese warned in a recent op-ed of the damaging effects of Trump's plan to end Social Security taxes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback